A heart transplant 62-year-old patient referred for coronavirus-19 disease (COVID-19) pneumonia. At admission, he was febrile, tachypnoeic, and mild hypoxic with dry cough; during hospitalization, a diffuse morbilliform skin rash appeared. He was treated with tocilizumab with symptoms improvement, without a complete pulmonary function recovery. Skin rash, highly suggestive for COVID-19 cutaneous involvement, persisted for ten days despite tocilizumab administration.
All Keywords
【저자키워드】 COVID-19, Tocilizumab, Pneumonia, heart transplant,
【저자키워드】 COVID-19, Tocilizumab, Pneumonia, heart transplant,